Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06547242
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-07
Brief Title:
Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Bioequivalence Trial of BC-T4CYS 150 µg Tablets Versus Letrox 150 µg in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration
Detailed Description:
Single centre open-label randomised order of treatments balanced 2-period 2-sequence single dose cross-over trial with administrations under fasting conditions separated by a washout period of at least 45 treatment-free days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None